当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Maintenance rituximab in mantle-cell lymphoma
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-10-05 , DOI: 10.1016/s1470-2045(17)30773-8
Talha Khan Burki

Maintenance rituximab therapy improves event-free survival compared with observation in patients with mantle-cell lymphoma and is associated with a low frequency of major infection after transplantation, according to a new study.

中文翻译:

维持利妥昔单抗治疗套细胞淋巴瘤

一项新的研究表明,与在套细胞淋巴瘤患者中观察到的情况相比,维持性利妥昔单抗疗法可改善无事件生存期,并且与低频率的重大感染发生率相关。
更新日期:2017-11-10
down
wechat
bug